Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders
Acne constitutes one of the most prevalent skin disorder affecting both skin and mental health of patients. However, no cure has been developed so far. In this area, Thymol constitutes a potential candidate since it is able to restore the healthy microbiota of the skin. However, its permeation prope...
| Autores: | , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2024 |
| País: | España |
| Institución: | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| Repositorio: | Recercat. Dipósit de la Recerca de Catalunya |
| OAI Identifier: | oai:recercat.cat:2445/219683 |
| Acceso en línea: | https://hdl.handle.net/2445/219683 |
| Access Level: | acceso abierto |
| Palabra clave: | Pell Nanopartícules Emulsions (Farmàcia) Skin Nanoparticles Emulsions (Pharmacy) |
| id |
ES_45e02e231ec6dfdc51ba1a585fbb8927 |
|---|---|
| oai_identifier_str |
oai:recercat.cat:2445/219683 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disordersFolle, CamilaSánchez-López, E. (Elena)Mallandrich Miret, MireiaDíaz-Garrido, NataliaSuñer Carbó, J. (Joaquim)Halbaut, LydaCarvajal Vidal, Paulina AndreaMarqués Villavecchia, Ana M.Espina García, MartaBadía Palacín, JosefaBaldomà Llavinés, LauraGarcía López, María LuisaCalpena Campmany, Ana CristinaPellNanopartículesEmulsions (Farmàcia)SkinNanoparticlesEmulsions (Pharmacy)Acne constitutes one of the most prevalent skin disorder affecting both skin and mental health of patients. However, no cure has been developed so far. In this area, Thymol constitutes a potential candidate since it is able to restore the healthy microbiota of the skin. However, its permeation properties cause its fast elimination and, to avoid this problem, thymol has been loaded into nanostructured lipid carriers (TH-NLCs). Moreover, to increase the suitability of these systems for skin applications, several surface functionalization strategies of TH-NLCs had been assessed. Among the different molecules, phosphatidylcholine-TH-NLCs demonstrated to be safe as well as to provide high antioxidant activity in cellular studies. Therefore, to administer these systems to the skin, functionalized TH-NLCs were dispersed into a carbomer gel developing semi-solid formulations. Rheological properties, porosity and extensibility of TH dispersed in carbomer as well as phosphatidylcholine-TH-NLCs were assessed demonstrating suitable properties for dermal applications. Moreover, both formulations were applied in healthy volunteers demonstrating that gel-phosphatidylcholine-TH-NLCs were able to increase in skin hydration, decrease water loss and reduce skin sebum. Therefore, gel-phosphatidylcholine-TH-NLCs proved to be a suitable system for skin pathologies linked with high sebum generation, loss of hydration and high oxidation, such as acne vulgaris. Keywords: Acne; Dermal; Lipid nanoparticles; Nanostructured lipid carriers; Thymol.Elsevier B.V.2025202520242025info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion1 p.application/pdfhttps://hdl.handle.net/2445/219683Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: https://doi.org/10.1016/j.ijpharm.2023.123732International Journal of Pharmaceutics, 2024, vol. 651https://doi.org/10.1016/j.ijpharm.2023.123732cc-by-nc-nd (c) Camila Folle, et al., 2024http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:recercat.cat:2445/2196832026-05-29T05:05:01Z |
| dc.title.none.fl_str_mv |
Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders |
| title |
Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders |
| spellingShingle |
Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders Folle, Camila Pell Nanopartícules Emulsions (Farmàcia) Skin Nanoparticles Emulsions (Pharmacy) |
| title_short |
Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders |
| title_full |
Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders |
| title_fullStr |
Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders |
| title_full_unstemmed |
Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders |
| title_sort |
Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders |
| dc.creator.none.fl_str_mv |
Folle, Camila Sánchez-López, E. (Elena) Mallandrich Miret, Mireia Díaz-Garrido, Natalia Suñer Carbó, J. (Joaquim) Halbaut, Lyda Carvajal Vidal, Paulina Andrea Marqués Villavecchia, Ana M. Espina García, Marta Badía Palacín, Josefa Baldomà Llavinés, Laura García López, María Luisa Calpena Campmany, Ana Cristina |
| author |
Folle, Camila |
| author_facet |
Folle, Camila Sánchez-López, E. (Elena) Mallandrich Miret, Mireia Díaz-Garrido, Natalia Suñer Carbó, J. (Joaquim) Halbaut, Lyda Carvajal Vidal, Paulina Andrea Marqués Villavecchia, Ana M. Espina García, Marta Badía Palacín, Josefa Baldomà Llavinés, Laura García López, María Luisa Calpena Campmany, Ana Cristina |
| author_role |
author |
| author2 |
Sánchez-López, E. (Elena) Mallandrich Miret, Mireia Díaz-Garrido, Natalia Suñer Carbó, J. (Joaquim) Halbaut, Lyda Carvajal Vidal, Paulina Andrea Marqués Villavecchia, Ana M. Espina García, Marta Badía Palacín, Josefa Baldomà Llavinés, Laura García López, María Luisa Calpena Campmany, Ana Cristina |
| author2_role |
author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Pell Nanopartícules Emulsions (Farmàcia) Skin Nanoparticles Emulsions (Pharmacy) |
| topic |
Pell Nanopartícules Emulsions (Farmàcia) Skin Nanoparticles Emulsions (Pharmacy) |
| description |
Acne constitutes one of the most prevalent skin disorder affecting both skin and mental health of patients. However, no cure has been developed so far. In this area, Thymol constitutes a potential candidate since it is able to restore the healthy microbiota of the skin. However, its permeation properties cause its fast elimination and, to avoid this problem, thymol has been loaded into nanostructured lipid carriers (TH-NLCs). Moreover, to increase the suitability of these systems for skin applications, several surface functionalization strategies of TH-NLCs had been assessed. Among the different molecules, phosphatidylcholine-TH-NLCs demonstrated to be safe as well as to provide high antioxidant activity in cellular studies. Therefore, to administer these systems to the skin, functionalized TH-NLCs were dispersed into a carbomer gel developing semi-solid formulations. Rheological properties, porosity and extensibility of TH dispersed in carbomer as well as phosphatidylcholine-TH-NLCs were assessed demonstrating suitable properties for dermal applications. Moreover, both formulations were applied in healthy volunteers demonstrating that gel-phosphatidylcholine-TH-NLCs were able to increase in skin hydration, decrease water loss and reduce skin sebum. Therefore, gel-phosphatidylcholine-TH-NLCs proved to be a suitable system for skin pathologies linked with high sebum generation, loss of hydration and high oxidation, such as acne vulgaris. Keywords: Acne; Dermal; Lipid nanoparticles; Nanostructured lipid carriers; Thymol. |
| publishDate |
2024 |
| dc.date.none.fl_str_mv |
2024 2025 2025 2025 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/2445/219683 |
| url |
https://hdl.handle.net/2445/219683 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Reproducció del document publicat a: https://doi.org/10.1016/j.ijpharm.2023.123732 International Journal of Pharmaceutics, 2024, vol. 651 https://doi.org/10.1016/j.ijpharm.2023.123732 |
| dc.rights.none.fl_str_mv |
cc-by-nc-nd (c) Camila Folle, et al., 2024 http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
cc-by-nc-nd (c) Camila Folle, et al., 2024 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
1 p. application/pdf |
| dc.publisher.none.fl_str_mv |
Elsevier B.V. |
| publisher.none.fl_str_mv |
Elsevier B.V. |
| dc.source.none.fl_str_mv |
Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) reponame:Recercat. Dipósit de la Recerca de Catalunya instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| instname_str |
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| reponame_str |
Recercat. Dipósit de la Recerca de Catalunya |
| collection |
Recercat. Dipósit de la Recerca de Catalunya |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869407191368204288 |
| score |
15,811543 |